ESR as a valuable tool for the investigation of the dynamics of EPC and EPC/cholesterol liposomes containing a carboranyl-nucleoside intended for BNCT

Application of drug delivery system to boron neutron capture therapy for cancer

BACKGROUND

Tumor cell destruction in boron neutron capture therapy (BNCT) is due to the nuclear reaction between (10)B and thermal neutrons ((10)B + (1)n --> (7)Li + (4)He (alpha) + 2.31 MeV (93.7 %)/2.79 MeV (6.3 %)). The resulting lithium ions and alphaparticles are high linear energy transfer (LET) particles which give a high biological effect. Their short range in tissue (5 - 9 mum) restricts radiation damage to those cells in which boron atoms are located at the time of neutron irradiation. BNCT has been applied clinically for the treatment of malignant brain tumors, malignant melanoma, head and neck cancer and hepatoma. Sodium mercaptoundecahydro-dodecaborate (Na(2)(10)B(12)H(11)SH: BSH) and borono-phenylalanine ((10)BPA) are currently being used in clinical treatments. These low molecule compounds are easily cleared from cancer cells and blood, so high accumulation and selective delivery of boron compounds into tumor tissues and cancer cells are most important to achieve effective BNCT and to avoid damage to adjacent healthy cells.

OBJECTIVE

In order to achieve the selective delivery of boron atoms to cancer cells, a drug delivery system (DDS) is an attractive intelligent technology for targeting and controlled release of drugs.

METHODS

We performed literature searches related to boron delivery systems in vitro and in vivo.

RESULTS

We describe several DDS technologies for boron delivery to cancer tissues and cancer cells from the past to current status. We are convinced that it will be possible to use liposomes, monoclonal antibodies and WOW emulsions as boron delivery systems for BNCT clinically in accordance with the preparation of good commercial product (GCP) grade materials.

Spin labelling study of interfacial properties of egg-phosphatidylcholine liposomes as a function of cholesterol concentrations

In order to gain insight into interfacial properties of liposomes composed of egg-phosphatidylcholine (egg-PC) and dihexadecyl-phosphate (DHP) as a function of 0, 8, 15, 29, 38, 45mol% of cholesterol, dynamic properties of two long-chain spin labels: TEMPO-stearate (2,2,6,6-tetramethylpiperidine-1-oxyl-4-yl)-octa-decanoate) and TEMPO-stearamide (2,2,6,6-tetramethylpiperidine-1-oxyl-4-yl)-octa-decanamide) were studied by CW-ESR spectroscopy. These spin labels reflect motional properties in the region of phospholipid head-groups. Two different environments of TEMPO-stearate were determined at 29, 38 and 45mol% of cholesterol. In the newly formed domain above 29mol%, N-O moiety of the spin label was surrounded by larger amount of bound water and experienced slower motion than in the cholesterol poor domain. The fraction of the second more hydrophilic environment of the spin label increased with cholesterol concentration. TEMPO-stearamide, a hydrogen-bond donor, reported more polar environment and slower motion than TEMPO-stearate even in the absence of cholesterol. Only one spin label environment was determined for all cholesterol concentrations. Slowing down of the TEMPO-stearamide motion was obtained even at 8mol% of cholesterol.